Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 267Breast Neoplasms 256Lung Neoplasms 130Prostatic Neoplasms 113Colorectal Neoplasms 106Carcinoma, Non-Small-Cell Lung 101Pancreatic Neoplasms 67Carcinoma, Hepatocellular 53Ovarian Neoplasms 50Stomach Neoplasms 49Multiple Myeloma 49Hematologic Neoplasms 48Urinary Bladder Neoplasms 47Brain Neoplasms 45Leukemia, Myeloid, Acute 42Melanoma 41Head and Neck Neoplasms 40Esophageal Neoplasms 40Disease 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Colonic Neoplasms 35Rectal Neoplasms 34Liver Neoplasms 34Lymphoma 32Neoplasm Metastasis 31Leukemia, Lymphocytic, Chronic, B-Cell 30Endometrial Neoplasms 30Uterine Cervical Neoplasms 27Thyroid Neoplasms 27Kidney Neoplasms 27

Interventions

Verapamil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Multi Drug Resistant Organisms × 90 days × Clear all
NCT07505446 2026-04-08

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Assiut University

Not yet recruiting
100 enrolled

Multi Drug Resistant Organisms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡